Cartesian Therapeutics, Inc. — Director's Dealing 2016

Jun 22, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21

Reporting Person: Osage University Partners II, L.P. (10% Owner)
Reporting Person: Osage University GP II, L.P. (10% Owner)
Reporting Person: Osage Partners, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70915	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series E Convertible Preferred Stock	$		Common Stock (284900)		Indirect

Footnotes

F1: Held by Osage University Partners II, L.P. ("Osage"). Osage Partners, LLC ("Osage Partners") is the general partner of Osage University GP II, LP ("Osage GP"), which is the general partner of Osage. Osage Partners and Osage GP may be deemed to share voting and investment power with respect to all shares held by Osage. Each of the filing persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.

F2: The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.